Docetaxel Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-02-20 · last update 2026-02-20
Manufacturers: Ingenus Pharmaceuticals LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 02/20/2026 Updated 02/20/2026 Discontinued 02/20/2026 |
| Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 02/20/2026 Updated 02/20/2026 Discontinued 02/20/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)